MATRIX ACTIVE SOLN.AC.CLEAN.BAR ACNE TREAT. 3 %
SULFUR : 3 % · DIN 02138638 · MATRIX ESSENTIALS INC.
Health Canada status: CANCELLED POST MARKET
What is MATRIX ACTIVE SOLN.AC.CLEAN.BAR ACNE TREAT.?
MATRIX ACTIVE SOLN.AC.CLEAN.BAR ACNE TREAT. 3 % contains SULFUR : 3 %. It is listed in the Health Canada Drug Product Database under DIN 02138638, held by MATRIX ESSENTIALS INC., supplied as SOAP BAR for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 29-May-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02138638 |
|---|---|
| Brand name | MATRIX ACTIVE SOLN.AC.CLEAN.BAR ACNE TREAT. |
| Generic / active ingredient | SULFUR : 3 % |
| Manufacturer | MATRIX ESSENTIALS INC. |
| Strength | 3 % |
| Dosage form | SOAP BAR |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D10AB02 SULPHUR |
| AHFS class | 84:28.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 29-May-2001 |
| Original market date | 1995-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D10AB02 SULPHUR. 0 of 30 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 5S BLEMISH TREATMENT | 3 % | CREAM | SHISEIDO AMERICA INC | CANCELLED POST MARKET | DIN 02239408 |
| ACNE BLEMISH CREAM(SULFUR CREAM) | 4 % | CREAM | BONNE BELL OF CANADA LTD. | CANCELLED POST MARKET | DIN 00692069 |
| ACNOMEL SKIN TONE CREAM | 11 % | CREAM | NUMARK LABORATORIES, INC. | CANCELLED POST MARKET | DIN 01925008 |
| ALMAY TROUBLE SPOTTER ACNE PIMPLE MEDICATION | 5 % | CREAM | ALMAY TORONTO INC. | CANCELLED POST MARKET | DIN 02030845 |
| ANTI-ACNE FORMULA FOR MEN | 3.75 % | CREAM | CLINIQUE LABORATORIES DIST | CANCELLED POST MARKET | DIN 00729744 |
| ANTI-ACNE FORMULA-LIGHT | 1 % | CREAM | CLINIQUE LABORATORIES DIST | CANCELLED POST MARKET | DIN 00695858 |
| ANTI-ACNE FORMULA-MEDIUM | 3.75 % | CREAM | CLINIQUE LABORATORIES DIST | CANCELLED POST MARKET | DIN 00695831 |
| CLEAR LOGIX OIL ABSORBENT ACNE MASK | 10 % | LOTION | ADVANCED RESEARCH LABORATORIES | CANCELLED POST MARKET | DIN 02231521 |
| CLEARASIL SKIN TONE ACNE CRM MEDICATION | .1 % | CREAM | RICHARDSON-VICKS, DIVISION OF THE PROCTER & GAMBLE COMPANY | CANCELLED POST MARKET | DIN 00730130 |
| CLEARASIL VANISHING ACNE CRM MEDICATION | 2 % | CREAM | RICHARDSON-VICKS, DIVISION OF THE PROCTER & GAMBLE COMPANY | CANCELLED POST MARKET | DIN 00730149 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for MATRIX ACTIVE SOLN.AC.CLEAN.BAR ACNE TREAT.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.